Joncquel Chevalier Curt Marie, Lecointe Karine, Mihalache Adriana, Rossez Yannick, Gosset Pierre, Léonard Renaud, Robbe-Masselot Catherine
Univ Lille Nord de France, Lille F-59000, France USTL, UGSF, IFR 147, Villeneuve d'Ascq F-59650, France CNRS, UMR 8576, Villeneuve d'Ascq F-59650, France.
Univ Lille Nord de France, Lille F-59000, France USTL, UGSF, IFR 147, Villeneuve d'Ascq F-59650, France CNRS, UMR 8576, Villeneuve d'Ascq F-59650, France UCLille, Lille F-59000, France Groupe Hospitalier de l'Institut Catholique Lillois/ Faculté Libre de Médecine, Service d'Anatomie Pathologie, Lille F-59000, France.
Glycobiology. 2015 Jun;25(6):617-31. doi: 10.1093/glycob/cwv004. Epub 2015 Jan 16.
Helicobacter pylori is a Gram-negative bacterium that colonizes the mucus niche of the gastric mucosa and infects more than half of the world's human population. Chronic infection may cause gastritis, duodenal ulcer, intestinal metaplasia or gastric cancer. In the stomach, H. pylori interacts with O-glycans of gastric mucins but the mechanism by which the bacteria succeed in altering the mucosa remains mainly unknown. To better understand the physiopathology of the infection, inhibitory adhesion assays were performed with various O-glycans expressed by human gastric mucins, and topographic expression of gastric mucins MUC5AC and MUC6 was analyzed for healthy uninfected individuals, for infected asymptomatic individuals and for patients infected by H. pylori and having the incomplete type of intestinal metaplasia. The glycosylation of the gastric mucosa of asymptomatic individuals infected by H. pylori was determined and compared with the glycosylation pattern found for patients with the incomplete type of intestinal metaplasia. Results show that H. pylori manages to modulate host's glycosylation during the course of infection in order to create a favorable niche, whereas asymptomatic infected individuals seem to counteract further steps of infection development by adapting their mucus glycosylation.
幽门螺杆菌是一种革兰氏阴性菌,它定殖于胃黏膜的黏液微环境中,感染了全球超过一半的人口。慢性感染可能会导致胃炎、十二指肠溃疡、肠化生或胃癌。在胃中,幽门螺杆菌与胃黏蛋白的O-聚糖相互作用,但细菌成功改变黏膜的机制仍主要未知。为了更好地理解感染的病理生理学,我们用人类胃黏蛋白表达的各种O-聚糖进行了抑制黏附试验,并分析了健康未感染个体、感染无症状个体以及感染幽门螺杆菌且患有不完全型肠化生的患者的胃黏蛋白MUC5AC和MUC6的拓扑表达。测定了幽门螺杆菌感染的无症状个体胃黏膜的糖基化情况,并与不完全型肠化生患者的糖基化模式进行了比较。结果表明,幽门螺杆菌在感染过程中设法调节宿主的糖基化以创造有利的微环境,而无症状感染个体似乎通过调整其黏液糖基化来对抗感染发展的进一步步骤。